Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07206407 · ClinicalTrials.gov registry record · NA
Clinical Trial on Rapid Immune Modulating Effects
A NA study of Immune Surveillance, sponsored by Natural Immune Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07206407 is a NA study of Immune Surveillance that is actively recruiting participants, run by Natural Immune Systems. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07206407, a NA study of Immune Surveillance, is actively recruiting participants, sponsored by Natural Immune Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal for this clinical trial is to document rapid effects of a nutritional blend on immune cells. A double-blind, placebo-controlled, cross-over study design will be used.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Nutraceutical blend
Study Locations (1)
Oregon
- NIS Labs - Klamath Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-09-28 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07206407
The ClinicalTrials.gov registry entry for NCT07206407 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natural Immune Systems, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Immune Surveillance appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07206407 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT07206407 about?
NCT07206407 is a clinical study titled "Clinical Trial on Rapid Immune Modulating Effects". The goal for this clinical trial is to document rapid effects of a nutritional blend on immune cells. A double-blind, placebo-controlled, cross-over study design will be used.
What is the current status of trial NCT07206407?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-09-28. Estimated completion is 2026-03-01.
What conditions does trial NCT07206407 study?
This clinical trial studies the following conditions: Immune Surveillance.
What interventions are being tested in trial NCT07206407?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Nutraceutical blend (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07206407?
This trial is sponsored by Natural Immune Systems, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07206407 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Immune Surveillance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.